ACADIA Pharmaceuticals
ACAD
#4034
Rank
NZ$5.40 B
Marketcap
NZ$31.28
Share price
-2.73%
Change (1 day)
-25.46%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2026 (TTM): NZ$3.70

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$3.89. In 2025 the company made an earnings per share (EPS) of NZ$4.24 an increase over its 2024 EPS that were of NZ$2.49.

EPS history for ACADIA Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$3.70-12.77%
2025NZ$4.2470.59%
2024NZ$2.49-457.89%
2023NZ-$0.69-71.64%
2022NZ-$2.4527.62%
2021NZ-$1.92-41.67%
2020NZ-$3.2912.5%
2019NZ-$2.92-17.95%
2018NZ-$3.56-17.02%
2017NZ-$4.300.43%
2016NZ-$4.2843.56%
2015NZ-$2.9873.4%
2014NZ-$1.72
2012NZ-$0.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.21 213.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.30-66.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.47 1,350.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.26 112.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
NZ-$8.45-316.90%๐Ÿ‡บ๐Ÿ‡ธ USA